Neurochemical dementia diagnostics: Assays in CSF and blood
Lewczuk P, Hornegger J, Zimmermann R, Otto M, Wiltfang J, Kornhuber J (2008)
Publication Type: Journal article, Original article
Publication year: 2008
Journal
Original Authors: Lewczuk P., Hornegger J., Zimmermann R., Otto M., Wiltfang J., Kornhuber J.
Publisher: Springer Verlag (Germany)
Book Volume: 258
Pages Range: 44-49
Journal Issue: null
DOI: 10.1007/s00406-008-5005-3
Abstract
In this review, current neurochemical dementia diagnostics (NDD) procedures are presented with a focus on biomarkers in the cerebrospinal fluid (CSF) and blood: amyloid β peptides, tau protein, and its phosphorylated form (pTau). CSF analysis is an increasingly important tool for early and differential diagnosis of dementia syndromes. Although lumbar puncture is a mildly invasive procedure with a low incidence of complications, establishing blood assays capable of reliably measuring NDD biomarkers is an aim of several studies worldwide. © 2008 Springer.
Authors with CRIS profile
Piotr Lewczuk
Department of Psychiatry and Psychotherapy
Joachim Hornegger
Lehrstuhl für Informatik 14 (Bild- und Sprachverarbeitung)
Johannes Kornhuber
Lehrstuhl für Psychiatrie und Psychotherapie
Involved external institutions
Germany (DE)How to cite
APA:
Lewczuk, P., Hornegger, J., Zimmermann, R., Otto, M., Wiltfang, J., & Kornhuber, J. (2008). Neurochemical dementia diagnostics: Assays in CSF and blood. European archives of psychiatry and clinical neuroscience, 258(null), 44-49. https://dx.doi.org/10.1007/s00406-008-5005-3
MLA:
Lewczuk, Piotr, et al. "Neurochemical dementia diagnostics: Assays in CSF and blood." European archives of psychiatry and clinical neuroscience 258.null (2008): 44-49.
BibTeX: Download